StockData
ATHENasdaqPharmaceutical PreparationsFiscal year ends June 30Also trades as PRNAF

ALTERITY THERAPEUTICS LTD

Financials through fiscal 2026, year ended Jun 30, 2026Last filing: 20-F on Aug 28, 2026
$2.43−0.19 (-7.25%)

Close on Oct 19, 2026

Earnings

Quarterly results announced on Form 8-K, Item 2.02

No earnings releases found

Alterity Therapeutics has not filed an earnings release (Form 8-K, Item 2.02) that we could match to a fiscal quarter.

Press releases

Announcements Alterity Therapeutics filed with the SEC